| Product NDC: | 61748-044 |
| Proprietary Name: | Aminocaproic Acid |
| Non Proprietary Name: | Aminocaproic Acid |
| Active Ingredient(s): | .25 g/mL & nbsp; Aminocaproic Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61748-044 |
| Labeler Name: | VersaPharm Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074759 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000301 |
| Package NDC: | 61748-044-16 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (61748-044-16) |
| NDC Code | 61748-044-16 |
| Proprietary Name | Aminocaproic Acid |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (61748-044-16) |
| Product NDC | 61748-044 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Aminocaproic Acid |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20000301 |
| Marketing Category Name | ANDA |
| Labeler Name | VersaPharm Incorporated |
| Substance Name | AMINOCAPROIC ACID |
| Strength Number | .25 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |